High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma.
about
Transarterial administration of integrin inhibitor loaded nanoparticles combined with transarterial chemoembolization for treating hepatocellular carcinoma in a rat modelMultidetector-row computed tomography in the management of hepatocellular carcinoma with transcatheter arterial chemoembolizationLipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data.Combined interventional therapies of hepatocellular carcinoma.Simultaneous injection of autologous mononuclear cells with TACE in HCC patients; preliminary study.Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.Transarterial therapies for hepatocellular carcinoma.Current treatment for liver metastases from colorectal cancer.Review article: intra-arterial treatments in patients with hepatocellular carcinoma.Downregulation of matrix metalloproteinases contributes to the inhibition of cell migration and invasion in HepG2 cells by sodium valproate.Gene expression profiles of hepatoma cell line HLE.Comparison of survival rates between patients treated with transcatheter arterial chemoembolization and hepatic resection for solitary hepatocellular carcinoma.An implantable rat liver tumor model for experimental transarterial chemoembolization therapy and its imaging features.Influence of transarterial chemoembolization on angiogenesis and expression of vascular endothelial growth factor and basic fibroblast growth factor in rat with Walker-256 transplanted hepatoma: an experimental study.Comparison of long-term effects between intra-arterially delivered ethanol and Gelfoam for the treatment of severe arterioportal shunt in patients with hepatocellular carcinoma.Derived neutrophil to lymphocyte ratio predicts prognosis for patients with HBV-associated hepatocellular carcinoma following transarterial chemoembolization.Liver embolizations in oncology: a review. Part I. Arterial (chemo)embolizations.Transcatheter arterial chemoembolization (TACE) with lipiodol to treat hepatocellular carcinoma: survey results from the TACE study group of Japan.Chemoembolization of hepatic malignancy.Cerebral and pulmonary embolisms after transcatheter arterial chemoembolization for hepatocellular carcinomaTherapeutic effect and tolerability of gelatin sponge particle-mediated chemoembolization for colorectal liver metastases: a retrospective study.131I-labeled metuximab combined with chemoembolization for unresectable hepatocellular carcinoma.Nonsurgical treatment for localized hepatocellular carcinoma.Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization).Treatment of intermediate-stage hepatocellular carcinoma.Management of people with intermediate-stage hepatocellular carcinoma: an attempted network meta-analysis.Radiofrequency ablation combined with transcatheter therapy in rabbit VX2 liver tumors: effects and histopathological characteristics.Fever after transcatheter arterial chemoembolization for hepatocellular carcinoma: incidence and risk factor analysis.Role of preoperative selective portal vein embolization in two-step curative hepatectomy for hepatocellular carcinoma.Transarterial chemoembolization combined with Huaier granule for the treatment of primary hepatic carcinoma: Safety and efficacy.Combined transarterial chemoembolization and arterial administration of Bletilla striata in treatment of liver tumor in rats.Liver microcirculation after hepatic artery embolization with degradable starch microspheres in vivoApplication of poly-lactide-co-glycolide-microspheres in the transarterial chemoembolization in an animal model of hepatocellular carcinoma.Activation of the intrinsic apoptosis pathway contributes to the induction of apoptosis in hepatocellular carcinoma cells by valproic acid.Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE.Effect of cantharidins in chemotherapy for hepatoma: a retrospective cohort study.Safety profile of sequential transcatheter chemoembolization with DC Bead™: results of 237 hepatocellular carcinoma (HCC) patients.Doxorubicin eluting beads - 1: effects of drug loading on bead characteristics and drug distribution.Lipiodol versus diaphragm in 4D-CBCT-guided stereotactic radiotherapy of hepatocellular carcinomas.Transarterial chemoembolization for patients with hepatocellular carcinoma.
P2860
Q24658607-CE9A07C9-875A-4F27-849F-33F9DD711583Q28242300-62FB8999-B6C4-48A0-895B-9DA149D4F9A6Q31036824-17F0E554-1811-4191-A7A3-221BACF6CC44Q31156779-B8E2889A-518E-4BB2-ADDB-372A14627AD5Q33736790-EB42267A-436B-4E7D-8D14-37BEF5E0D587Q34581507-EF884474-509D-4FA8-9B93-FCD79AC2F8DDQ34628257-6B8C0484-FA79-44DE-96C9-088B5A8DAF95Q35047600-AFC070A9-5BC3-4B66-B673-6F4C01B5C404Q35145069-541F14CB-8937-4407-AF21-07E8262ECA49Q35804013-8D1CD3E0-FC0E-4181-9492-5EA7DBED921EQ36178624-5ED08010-D1B0-458E-9FBC-083BFADBEE36Q36217074-E16198EE-4C0B-4B20-915D-C57D3AB673BDQ36308373-12E1D2C4-F09D-4C57-A563-9D670D0A268AQ36308821-397F2E30-540A-42AD-BAB9-884AFE2DE3C8Q36502575-45A870CA-A218-461C-99B1-F7211B309968Q36824936-F94B67C2-6C18-41C1-8AF0-49166878B829Q37054978-D255EA5E-97BC-48E3-A35F-E33443FFEE13Q37128777-9669D956-5275-421A-A3EE-B3A32473B614Q37230931-72621DF9-4D77-4FC6-9BA8-F5BECCDFE0C0Q37249594-C77E2FC9-B1C2-4352-AB52-7AF9A6E93BA7Q37357133-C557C23B-2276-455D-9EC8-6478C2A0950CQ37408971-4726426A-A769-4B63-A602-4EB4B1C167EFQ37578521-E0072044-BE8E-4138-AE84-C58BDD55323DQ37876332-21E11F3C-86A4-400B-8F87-C0BC9B923A58Q38236876-22753078-0255-4F9D-AB94-510681A833CCQ38747707-0E13DEB0-86A2-4D54-8202-0620A795AD7BQ39034301-0862B038-A35C-453F-BA50-9ED57FB890F7Q40402157-87586E8C-D95F-4AE8-A3BD-3C6ED795A311Q40552306-2E318163-324B-493B-99A5-A0D6CD512574Q41091212-39318B01-6DA3-4BA7-B773-01E3624C504AQ41771459-CF8DEDD7-5BFE-41D9-9290-82A2868B50C3Q42725848-A9D0F61F-3941-43E2-8030-41E0868A29EEQ43066620-8FE5134F-19D8-483C-9AF3-76D8D633526AQ43113971-C0B9E6F0-5320-4DC2-BD3B-59BAF7516C4DQ43159874-B29EC3CF-F9D9-408D-AF35-E0CD2F018589Q47638564-98451A3A-F3FD-4A82-AD0E-E9CB45E6D981Q50179074-B9931126-139C-4DCE-A23A-A147BA62BE9DQ51010885-B571E975-6DB4-4BD1-8E14-49DC173881EAQ51618126-D36C436B-23C0-4E9F-9345-6B951AF9C1DFQ51905707-DB786F95-4E88-4670-846C-89941B6EB249
P2860
High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
High-dose iodized oil transcat ...... arge hepatocellular carcinoma.
@ast
High-dose iodized oil transcat ...... arge hepatocellular carcinoma.
@en
type
label
High-dose iodized oil transcat ...... arge hepatocellular carcinoma.
@ast
High-dose iodized oil transcat ...... arge hepatocellular carcinoma.
@en
prefLabel
High-dose iodized oil transcat ...... arge hepatocellular carcinoma.
@ast
High-dose iodized oil transcat ...... arge hepatocellular carcinoma.
@en
P2093
P2860
P356
P1476
High-dose iodized oil transcat ...... arge hepatocellular carcinoma.
@en
P2093
Guo-Hui Li
Jin-Qing Li
Min-Shan Chen
Wei-Zhang Zhang
Xiao-Jun Lin
Ya-Qi Zhang
Yong-Ping Guo
Yun-Fei Yuan
P2860
P356
10.3748/WJG.V8.I1.74
P407
P577
2002-02-01T00:00:00Z